title: Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus.
abstract: Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves multiple interacting cell types driven by numerous cytokines and autoimmune epitopes. Although the initiating events leading to SLE pathology are not understood, there is a growing realization that dysregulated cytokine action on immune cells plays an important role in promoting the inflammatory autoimmune state. We applied phospho-specific flow cytometry to characterize the extent to which regulation of cytokine signal transduction through the STAT family of transcription factors is disturbed during the progression of SLE. Using a panel of 10 cytokines thought to have causal roles in the disease, we measured signaling responses at the single-cell level in five immune cell types from the MRLlpr murine model. This generated a highly multiplexed view of how cytokine stimuli are processed by intracellular signaling networks in adaptive and innate immune cells during different stages of SLE pathogenesis. We report that robust changes in cytokine signal transduction occur during the progression of SLE in multiple immune cell subtypes including increased T cell responsiveness to IL-10 and ablation of Stat1 responses to IFNalpha, IFNgamma, IL-6, and IL-21, Stat3 responses to IL-6, Stat5 responses to IL-15, and Stat6 responses to IL-4. We found increased intracellular expression of Suppressor of Cytokine Signaling 1 protein correlated with negative regulation of Stat1 responses to inflammatory cytokines. The results provide evidence of negative feedback regulation opposing inflammatory cytokines that have self-sustaining activities and suggest a cytokine-driven oscillator circuit may drive the periodic disease activity observed in many SLE patients.
authors.affiliation: The Baxter Laboratory of Genetic Pharmacology, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
authors.forename: Matthew B
authors.initials: MB
authors.lastname: Hale
authors.forename: Peter O
authors.initials: PO
authors.lastname: Krutzik
authors.forename: Shamsher S
authors.initials: SS
authors.lastname: Samra
authors.forename: Janelle M
authors.initials: JM
authors.lastname: Crane
authors.forename: Garry P
authors.initials: GP
authors.lastname: Nolan
mesh_terms: D000818:Animals; D015153:Blotting, Western; D016207:Cytokines / Q000378:metabolism*; D018450:Disease Progression; D008180:Lupus Erythematosus, Systemic / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050791:STAT Transcription Factors / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D016207:Cytokines; D050791:STAT Transcription Factors
references.citation: J Immunol. 1982 Dec;129(6):2612-5
references.pmid: 6815273
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
references.pmid: 12604793
references.citation: J Immunol. 2004 Mar 1;172(5):2731-8
references.pmid: 14978070
references.citation: Nature. 1997 Jun 26;387(6636):917-21
references.pmid: 9202125
references.citation: Immunol Rev. 2008 Jun;223:39-59
references.pmid: 18613829
references.citation: Ann N Y Acad Sci. 2005 Dec;1062:146-54
references.pmid: 16461797
references.citation: Virology. 1999 Mar 30;256(1):8-14
references.pmid: 10087221
references.citation: Curr Opin Immunol. 2004 Dec;16(6):801-7
references.pmid: 15511676
references.citation: J Exp Med. 1994 Jan 1;179(1):305-10
references.pmid: 8270873
references.citation: Nature. 1997 Jun 26;387(6636):921-4
references.pmid: 9202126
references.citation: J Immunol. 2005 Jun 1;174(11):6791-802
references.pmid: 15905520
references.citation: Annu Rev Immunol. 1998;16:293-322
references.pmid: 9597132
references.citation: J Exp Med. 1990 Jul 1;172(1):7-12
references.pmid: 2141631
references.citation: Biochem J. 2004 Mar 1;378(Pt 2):449-60
references.pmid: 14611646
references.citation: Cytometry A. 2003 Oct;55(2):61-70
references.pmid: 14505311
references.citation: Immunol Rev. 2003 Apr;192:196-211
references.pmid: 12670405
references.citation: Acta Oncol. 1991;30(4):537-40
references.pmid: 1854511
references.citation: J Autoimmun. 2003 Feb;20(1):15-25
references.pmid: 12604309
references.citation: Arthritis Rheum. 1981 Nov;24(11):1396-1402
references.pmid: 6172132
references.citation: J Immunol. 2005 Aug 15;175(4):2366-73
references.pmid: 16081807
references.citation: Cell. 2004 Jul 23;118(2):217-28
references.pmid: 15260991
references.citation: J Immunol. 2005 Aug 15;175(4):2357-65
references.pmid: 16081806
references.citation: Inflamm Res. 1999 May;48(5):255-61
references.pmid: 10391113
references.citation: J Exp Med. 2003 Mar 17;197(6):777-88
references.pmid: 12642605
references.citation: Immunol Res. 2002;25(2):143-53
references.pmid: 11999168
references.citation: Science. 2008 Jul 4;321(5885):126-9
references.pmid: 18599789
references.citation: Cell. 1996 May 3;85(3):303-6
references.pmid: 8616885
references.citation: Cell. 1998 May 1;93(3):385-95
references.pmid: 9590173
references.citation: Nat Immunol. 2003 Jun;4(6):540-5
references.pmid: 12754505
references.citation: Immunity. 2006 Sep;25(3):383-92
references.pmid: 16979570
references.citation: J Biol Chem. 2003 Jan 3;278(1):661-71
references.pmid: 12403768
references.citation: Semin Immunol. 2004 Dec;16(6):351-65
references.pmid: 15541651
references.citation: Clin Exp Immunol. 1999 Jan;115(1):189-95
references.pmid: 9933441
references.citation: Science. 2005 Apr 22;308(5721):523-9
references.pmid: 15845847
references.citation: J Clin Invest. 1998 Jan 15;101(2):364-71
references.pmid: 9435308
references.citation: Genes Immun. 2006 Mar;7(2):156-68
references.pmid: 16508641
references.citation: Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13130-4
references.pmid: 9789053
references.citation: J Immunol. 2004 Jul 15;173(2):737-46
references.pmid: 15240659
references.citation: Rheum Dis Clin North Am. 1998 May;24(2):423-56
references.pmid: 9606766
references.citation: EMBO J. 1999 Mar 1;18(5):1309-20
references.pmid: 10064597
references.citation: Science. 2001 Nov 16;294(5546):1540-3
references.pmid: 11711679
references.citation: Curr Biol. 2005 Dec 6;15(23):R961-3
references.pmid: 16332526
references.citation: J Exp Med. 1978 Nov 1;148(5):1198-215
references.pmid: 309911
references.citation: Nucleic Acids Res. 1998 Jan 1;26(1):362-7
references.pmid: 9399875
references.citation: Clin Exp Immunol. 2000 Dec;122(3):464-70
references.pmid: 11122256
references.citation: Arthritis Rheum. 2000 Aug;43(8):1790-800
references.pmid: 10943869
references.citation: J Exp Med. 1999 Jun 7;189(11):1799-814
references.pmid: 10359584
references.citation: Lupus. 2000;9(9):664-71
references.pmid: 11199920
references.citation: J Clin Invest. 2000 Jul;106(2):207-15
references.pmid: 10903336
references.citation: Nat Biotechnol. 2002 Feb;20(2):155-62
references.pmid: 11821861
references.citation: J Exp Med. 2003 Mar 17;197(6):711-23
references.pmid: 12642603